Park West Asset Management LLC Angion Biomedica Corp. Transaction History

Park West Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.94 - $1.23 $277,507 - $363,121	295,221 Added 391.01%	370,724 $341,000
Q2 2022 Aug 15, 2022	BUY	$1.1 - $2.23 $83,053 - $168,371	75,503 New	75,503 $86,000
Q4 2021 Feb 14, 2022	SELL	$2.35 - $9.95 $2.45 Million - $10.4 Million	-1,041,776 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.31 - $13.25 $330,383 - $470,202	35,487 Added 3.53%	1,041,776 $10.2 Million
Q2 2021 Aug 16, 2021	BUY	$13.02 - $17.83 $516,047 - $706,692	39,635 Added 4.1%	1,006,289 $13 Million
Q1 2021 May 17, 2021	BUY	$15.01 - $25.74 $14.5 Million - $24.9 Million	966,654 New	966,654 $17 Million

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of Park West Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Park West Asset Management LLC with notifications on news.